Repurposing rheumatology drugs for COVID-19: Interleukin inhibitors
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to Cart failed.
Please try again later
Add to Wish List failed.
Please try again later
Remove from wishlist failed.
Please try again later
Adding to library failed
Please try again
Follow podcast failed
Please try again
Unfollow podcast failed
Please try again
Repurposing rheumatology drugs for COVID-19: Interleukin inhibitors
-
Narrated by:
-
By:
About this listen
Cristina Mussini discusses the current data on interleukin inhibitors for the treatment of COVID-19 and explores why tocilizumab has been associated with beneficial outcomes in some studies but not others.
No reviews yet